Spear Bio secures $45 million in oversubscribed Series A financing to accelerate product launch for protein research and disease diagnostics - News-Medical
Spear Bio secures $45 million in oversubscribed Series A financing to accelerate product launch for protein research and disease diagnostics News-Medical